
Autotaxin-IN-5 (compound 63), extracted from patent WO2018212534A1, is an Autotaxin ингибитор. Autotaxin-IN-5 has the potential to treat idiopathic pulmonary fibrosis.
Autotaxin-IN-5 (compound 63), extracted from patent WO2018212534A1, is an Autotaxin inhibitor. Autotaxin-IN-5 has the potential to treat idiopathic pulmonary fibrosis.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.